Gross Profit Margin | 41.67 % |
Net Income Per EBT | 77.19 % |
Net Profit Margin | 10.13 % |
Return on Assets | 6.02 % |
Return on Equity | 24.93 % |
Dividend Yield (FWD) | 0.22 % |
Dividend Per Share | $0.155 |
Payout Ratio | 2.76 % |
Payout Date | Nil |
Ex-Dividend Date | Nil |
Latest Announced Dividend | Nil |
Revenue | $19.67B |
Gross Profit | $8.21B |
Gross Profit Ratio | 41.71% |
EBITDA | $3.67B |
Net Income | $1.99B |
EPS Diluted | 4.34 |
Long Term Debt | $0B |
Total Liabilities | $24.44B |
Total Equity | $8.63B |
Total Investments | $0.37B |
Total Debt | $1.5B |
Total Assets | $33.09B |
Net Income | $2.05B |
Inventory | $-0.08B |
Dividends Paid | $-0.06B |
Operating Cash Flow | $1.95B |
Capital Expenditure | $-0.4B |
The price of GE HealthCare Technologies Inc. (GEHCV) is 56 and it was updated on 2025-04-06 01:35:49.
Currently GE HealthCare Technologies Inc. (GEHCV) is in undervalued.
Sector | |
Industry |